• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG AS ENDURO TIBIA HEMI-WEDGE T1 12MM RL/LM; PREVIOUSLY REPORTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG AS ENDURO TIBIA HEMI-WEDGE T1 12MM RL/LM; PREVIOUSLY REPORTED Back to Search Results
Model Number NB037Z
Device Problem Break (1069)
Patient Problems Fall (1848); Failure of Implant (1924)
Event Date 04/03/2017
Event Type  Injury  
Manufacturer Narrative
Manufacturing site evaluation: investigation on-going.Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that there was an issue with as enduro tibial components.The pre-operative diagnosis in (b)(6) 2016 was status post knee revision with multi-directional instability.The patient was initially implanted with enduro components on (b)(6) 2016.The type of cement used in this surgery was one-on-one with tobramycin placement of stimulan antibiotic load pellets with 240mg of tobramycin follow by 100mg of vancomycin per mixture.She experienced a fall in (b)(6) 2017 and had complaints of pain; imaging results showed a peri-prosthetic tibial fracture.There was a failed right total knee, revision due to failure of the tibial implant with some black debridement on (b)(6) 2017.A revision surgery was necessary.The implant that was revised was the aesculap enduro tibia.There had been signs of loosening but no acute inflammation.Treatment provided included intraoperative ancef and also tranexamic acid.Additional information was requested.The adverse event is filed under xc (b)(4).Associated medwatch-reports: ((b)(4)), 2916714-2020-00089 ((b)(4)).
 
Manufacturer Narrative
Associated medwatch-reports: 2916714-2020-00078 (400468255).2916714-2020-00089 (400468931).General information we received a complaint regarding enduro components.This is one of 12 cases regarding "problems with enduro components", "implant loosening" and "black debris".Consequences for the patient post-operative medical intervention was necessary: revision surgery.Investigation: no product at hand, therefore an investigation at the devices is not possible.Batch history review: due to the fact that no lot numbers were provided, a review of the device history records must remain incomplete.Conclusion and root cause: based on the information available it is not possible to determine a definitive root cause for the failure at that time.In this case it could be probable that the failure is partially patient related.Rationale: on the basis of the current information and without a product for investigation, a clear conclusion/root cause for the implant loosening can not be drawn.Corrective action: product safety case was created.
 
Event Description
No updates.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AS ENDURO TIBIA HEMI-WEDGE T1 12MM RL/LM
Type of Device
PREVIOUSLY REPORTED
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
MDR Report Key9934080
MDR Text Key187397071
Report Number2916714-2020-00078
Device Sequence Number1
Product Code KRO
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup
Report Date 07/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/08/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNB037Z
Device Catalogue NumberNB037Z
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date06/09/2020
Event Location Hospital
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-